Article(id=1329529142061674853, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329529021181833654, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2024.07.016, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1704988800000, receivedDateStr=2024-01-12, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794914048923, onlineDateStr=2026-11-17, pubDate=1720540800000, pubDateStr=2024-07-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794914048923, onlineIssueDateStr=2026-11-17, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794914048923, creator=13701087609, updateTime=1794914048923, updator=13701087609, issue=Issue{id=1329529021181833654, tenantId=1146029695717560320, journalId=1319690329412173987, year='2024', volume='45', issue='7', pageStart='697', pageEnd='798', issueExtLink='null', onlineDate='null', pubDate='1720540800000', pubDateStr='2024-07-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794914020104, creator='13701087609', updateTime=1794988140586, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329839905410233043, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329529021181833654, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329839905410233044, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329529021181833654, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=794, endPage=798, ext={EN=ArticleExt(id=1329529142703403366, articleId=1329529142061674853, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Progress in clinical research of subcutaneous immunoglobulin, columnId=1325221194584162830, journalTitle=World Clinical Drug, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

Immunoglobulin is recognized to be used for the treatment of various diseases, not only because it can serve as an alternative therapy against infections, but also because of its immunomodulatory effects. Appropriate use of immunoglobulins can save lives. However, its route of administration may lead to many adverse events and potential other adverse consequences. At present, intravenous immunoglobulin is the main clinical use in China, but there are more adverse events in the process of clinical use, and the patient compliance is not high. Due to this unmet clinical need, subcutaneous immunoglobulin (SCIg) has been developed abroad, which has been used in multiple clinical indications. However, SCIg in China is still in the early stage of exploration and research and development. Faced with the huge clinical needs in China, domestic blood product research and development companies have been encouraged to accelerate the research and development of SCIg drugs of different specifications and different indications to meet the treatment needs of domestic patients. This article reviewed the latest clinical research progress of SCIg in the treatment of primary immunodeficiency diseases, autoimmune neuromuscular diseases and other rare diseases, in order to provide new research and development ideas and suggestions for blood product research and development enterprises in China.

, authors=Zhilong LAN1, Lei WANG2, Song ZHANG2, Zhihui LI2, Junlong WANG1, *, Na NI1, *, authorsList=Zhilong LAN, Lei WANG, Song ZHANG, Zhihui LI, Junlong WANG, Na NI, authorCompany=null, correspAuthors=Junlong WANG, Na NI, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329529145140293991, articleId=1329529142061674853, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=皮下注射人免疫球蛋白药物的临床研究进展, columnId=1325221194743546384, journalTitle=世界临床药物, columnName=综述评论, runingTitle=null, highlight=null, articleAbstract=

免疫球蛋白被认为可用于治疗多种疾病,不仅因其能够作为替代疗法对抗感染,而且还具有免疫调节作用。适当使用免疫球蛋白能挽救生命。然而,其给药途径可能会导致许多不良反应和潜在的其他不良后果,目前国内临床上使用的以静脉注射免疫球蛋白为主,但在临床使用过程中不良反应偏多,患者依从性也不高。迫于这种未被满足的临床需求,在国外研制出皮下注射人免疫球蛋白(subcutaneous immunoglobulin,SCIg),目前已在多个临床适应证领域被应用,但国内SCIg尚处于前期探索和研发阶段,面对国内巨大的临床需求,促使国内血液制品研发企业加快研发不同规格及针对不同适应证的SCIg药物。该文主要就SCIg在治疗原发性免疫缺陷病、自身免疫性神经肌肉疾病及其他罕见病领域最新临床研究进展作综述,以期为我国血液制品研发企业提供新的研发思路及建议。

, authors=兰志龙1, 王磊2, 张松2, 李智慧2, 王俊龙1, *, 倪娜1, *, authorsList=兰志龙, 王磊, 张松, 李智慧, 王俊龙, 倪娜, authorCompany=null, correspAuthors=王俊龙, 倪娜, authorNote=

兰志龙,硕士研究生,研究方向:临床药学及临床研究。

, correspAuthorsNote=
倪娜,副研究员,研究方向:创新药物的临床研究。
王俊龙,副研究员,研究方向:创新药物的临床研究。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=v6YCTLMU6FK2zVoVkJKHrQ==, magXml=5Ivu57Rja1YNyDZlIe5Cgg==, pdfUrl=null, pdf=KTJCPz9La7IoQbU3zjUyRQ==, pdfFileSize=1524647, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=Z2f1R1xMz3+EqVfDOUsTXA==, mapNumber=null, fund=null)}, authors=[Author(id=1329529146180481391, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329529146390196593, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, authorId=1329529146180481391, language=EN, stringName=Zhilong LAN, firstName=Zhilong, middleName=null, lastName=LAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329529146620883314, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, authorId=1329529146180481391, language=CN, stringName=兰志龙, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国医药工业研究总院药物临床研究中心,上海 200437, bio={"content":"

兰志龙,硕士研究生,研究方向:临床药学及临床研究。

"}, bioImg=null, bioContent=

兰志龙,硕士研究生,研究方向:临床药学及临床研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329529145769439592, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, xref=1., ext=[AuthorCompanyExt(id=1329529145777828201, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, companyId=1329529145769439592, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1329529145786216810, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, companyId=1329529145769439592, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院药物临床研究中心,上海 200437)])]), Author(id=1329529146801238388, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329529148407656823, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, authorId=1329529146801238388, language=EN, stringName=Lei WANG, firstName=Lei, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Shanghai InnoClinic Pharmaceutical Development Co, Ltd., Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329529148562846072, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, authorId=1329529146801238388, language=CN, stringName=王磊, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.上海益临思医药开发有限公司,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329529146016903531, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, xref=2., ext=[AuthorCompanyExt(id=1329529146033680748, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, companyId=1329529146016903531, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai InnoClinic Pharmaceutical Development Co, Ltd., Shanghai 200437, China), AuthorCompanyExt(id=1329529146071429485, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, companyId=1329529146016903531, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海益临思医药开发有限公司,上海 200437)])]), Author(id=1329529148869030266, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329529148986470780, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, authorId=1329529148869030266, language=EN, stringName=Song ZHANG, firstName=Song, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Shanghai InnoClinic Pharmaceutical Development Co, Ltd., Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329529149233934717, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, authorId=1329529148869030266, language=CN, stringName=张松, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.上海益临思医药开发有限公司,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329529146016903531, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, xref=2., ext=[AuthorCompanyExt(id=1329529146033680748, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, companyId=1329529146016903531, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai InnoClinic Pharmaceutical Development Co, Ltd., Shanghai 200437, China), AuthorCompanyExt(id=1329529146071429485, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, companyId=1329529146016903531, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海益临思医药开发有限公司,上海 200437)])]), Author(id=1329529149351375231, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329529149426872705, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, authorId=1329529149351375231, language=EN, stringName=Zhihui LI, firstName=Zhihui, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Shanghai InnoClinic Pharmaceutical Development Co, Ltd., Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329529149552701826, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, authorId=1329529149351375231, language=CN, stringName=李智慧, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.上海益临思医药开发有限公司,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329529146016903531, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, xref=2., ext=[AuthorCompanyExt(id=1329529146033680748, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, companyId=1329529146016903531, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai InnoClinic Pharmaceutical Development Co, Ltd., Shanghai 200437, China), AuthorCompanyExt(id=1329529146071429485, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, companyId=1329529146016903531, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海益临思医药开发有限公司,上海 200437)])]), Author(id=1329529149649170820, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329529149728862598, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, authorId=1329529149649170820, language=EN, stringName=Junlong WANG, firstName=Junlong, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329529149812748679, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, authorId=1329529149649170820, language=CN, stringName=王俊龙, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.中国医药工业研究总院药物临床研究中心,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329529145769439592, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, xref=1., ext=[AuthorCompanyExt(id=1329529145777828201, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, companyId=1329529145769439592, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1329529145786216810, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, companyId=1329529145769439592, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院药物临床研究中心,上海 200437)])]), Author(id=1329529149955355017, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, orderNo=5, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329529150110544267, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, authorId=1329529149955355017, language=EN, stringName=Na NI, firstName=Na, middleName=null, lastName=NI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329529150269927820, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, authorId=1329529149955355017, language=CN, stringName=倪娜, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.中国医药工业研究总院药物临床研究中心,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329529145769439592, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, xref=1., ext=[AuthorCompanyExt(id=1329529145777828201, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, companyId=1329529145769439592, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1329529145786216810, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, companyId=1329529145769439592, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院药物临床研究中心,上海 200437)])])], keywords=[Keyword(id=1329529150387368333, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, language=EN, orderNo=1, keyword=subcutaneous immunoglobulin), Keyword(id=1329529150454477198, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, language=EN, orderNo=2, keyword=primary immunodeficiency diseases), Keyword(id=1329529150592889231, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, language=EN, orderNo=3, keyword=autoimmune neuromuscular diseases), Keyword(id=1329529150752272784, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, language=EN, orderNo=4, keyword=rare diseases), Keyword(id=1329529150920044945, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, language=CN, orderNo=1, keyword=皮下注射人免疫球蛋白), Keyword(id=1329529151041679762, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, language=CN, orderNo=2, keyword=原发性免疫缺陷病), Keyword(id=1329529151226229139, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, language=CN, orderNo=3, keyword=自身免疫性神经肌肉疾病), Keyword(id=1329529152799093140, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, language=CN, orderNo=4, keyword=罕见病)], refs=[Reference(id=1329529152945893781, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Mahlaoui N, Fouyssac F, Mazingue F, et al. Real-world experience with CLAIRYG® 50 mg/ml (intravenous immunoglobulin) in children under 12 years with primary immunodeficiency or immmune thrombocytopenia: a post-approval safety study[J]. Front Pediatr, 2023, 11: 1260296., articleTitle=null, refAbstract=null), Reference(id=1329529153122054550, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Marie I, Chérin P, Michallet M, et al. Management of adverse effects related to human immunoglobulin therapy: recommendations for clinical practice[J]. Rev Med Interne, 2017, 38(5): 312-319., articleTitle=null, refAbstract=null), Reference(id=1329529153319186839, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=张巍, 徐继轩, 叶生亮, 等. 皮下注射免疫球蛋白的发展及临床应用[J]. 中国药房, 2020, 31(3): 378-384., articleTitle=null, refAbstract=null), Reference(id=1329529153478570392, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Späth PJ, Schneider C, von Gunten S. Clinical use and therapeutic potential of IVIg/SCIg, plasma-derived IgA or IgM, and other alternative immunoglobulin preparations[J]. Arch Immunol Ther Exp (Warsz), 2017, 65(3): 215-231., articleTitle=null, refAbstract=null), Reference(id=1329529153709257113, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Menon D, Sarpong E, Bril V. Practical aspects of transitioning from intravenous to subcutaneous immunoglobulin therapy in neuromuscular disorders[J]. Can J Neurol Sci, 2022, 49(2): 161-167., articleTitle=null, refAbstract=null), Reference(id=1329529153851863451, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Guo Y, Tian X, Wang X, et al. Adverse effects of immunoglobulin therapy[J]. Front Immunol, 2018, 9: 1299., articleTitle=null, refAbstract=null), Reference(id=1329529153969303964, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Pecoraro A, Crescenzi L, Granata F, et al. Immunoglobulin replacement therapy in primary and secondary antibody deficiency: the correct clinical approach[J]. Int Immunopharmacol, 2017, 52: 136-142., articleTitle=null, refAbstract=null), Reference(id=1329529154145464733, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Beecher G, Anderson D, Siddiqi ZA. Subcutaneous immunoglobulin in myasthenia gravis exacerbation: a prospective, open-label trial[J]. Neurology, 2017, 89(11): 1135-1141., articleTitle=null, refAbstract=null), Reference(id=1329529154258710942, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Anderson-Smits C, Park M, Bell J, et al. Subcutaneous immunoglobulin use in immunoglobulin-naive patients with primary immunodeficiency: a systematic review[J]. Immunotherapy, 2022, 14(5): 373-387., articleTitle=null, refAbstract=null), Reference(id=1329529154334208415, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Tangye SG, Al-Herz W, Bousfiha A, et al. Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee[J]. J Clin Immunol, 2020, 40(1): 24-64., articleTitle=null, refAbstract=null), Reference(id=1329529154443260320, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Farmer JR, Foldvari Z, Ujhazi B, et al. Outcomes and treatment strategies for autoimmunity and hyperinflammation in patients with RAG deficiency[J]. J Allergy Clin Immunol Pract, 2019, 7(6): 1970-1985., articleTitle=null, refAbstract=null), Reference(id=1329529154581672353, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Thalappil S, Khalil S, Hassini S, et al. Subcutaneous immunoglobulin therapy for adult patients with primary immunodeficiency disease: qatar experience[J]. Qatar Med J, 2023, (2): 3., articleTitle=null, refAbstract=null), Reference(id=1329529154917216675, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Milota T, Bloomfield M, Kralickova P, et al. Czech hizentra noninterventional study with rapid push: efficacy, safety, tolerability, and convenience of therapy with 20% subcutaneous immunoglobulin[J]. Clin Ther, 2019, 41(11): 2231-2238., articleTitle=null, refAbstract=null), Reference(id=1329529155064017316, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Bonilla FA. Intravenous and subcutaneous immunoglobulin G replacement therapy[J]. Allergy Asthma Proc, 2016, 37(6): 426-431., articleTitle=null, refAbstract=null), Reference(id=1329529155252760997, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Bonilla FA, Khan DA, Ballas ZK, et al. Practice parameter for the diagnosis and management of primary immunodeficiency[J]. J Allergy Clin. Immunol, 2015, 136(5): 1186-1205., articleTitle=null, refAbstract=null), Reference(id=1329529155500224934, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Krivan G, Jolles S, Granados EL, et al. New insights in the use of immunoglobulins for the management of immune deficiency (PID) patients[J]. Am J Clin Exp Immunol, 2017, 6(5): 76-83., articleTitle=null, refAbstract=null), Reference(id=1329529155651219879, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Jolles S, Stein MR, Longhurst HJ, et al. New frontiers in subcutaneous immunoglobulin treatment[J]. Biol Ther, 2011, 1(1): 3., articleTitle=null, refAbstract=null), Reference(id=1329529157303775657, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Hagan JB, Fasano MB, Spector S, et al. Efficacy and safety of a new 20% immunoglobulin preparation for subcutaneous administration, IgPro20, in patients with primary immunodeficiency[J]. J Clin Immunol, 2010, 30(5): 734-745., articleTitle=null, refAbstract=null), Reference(id=1329529157496713642, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Tortorici MA, Lawo JP, Weide R, et al. Privigen® has similar pharmacokinetic properties in primary and secondary immune deficiency[J]. Int Immunopharmacol, 2019, 66: 119-126., articleTitle=null, refAbstract=null), Reference(id=1329529157651902892, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Sanders DB. Advancing research in autoimmune neuromuscular disorders[J]. Lancet Neurol, 2022, 21(2): 108-110., articleTitle=null, refAbstract=null), Reference(id=1329529157765149101, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Farrugia ME, Vincent A. Autoimmune mediated neuromuscular junction defects[J]. Curr Opin Neurol, 2010, 23(5): 489-495., articleTitle=null, refAbstract=null), Reference(id=1329529157911949742, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Vallat JM, Sommer C, Magy L. Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition[J]. Lancet Neurol, 2010, 9(4): 402-412., articleTitle=null, refAbstract=null), Reference(id=1329529158062944687, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Mathey EK, Park SB, Hughes RAC, et al. Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype[J]. J Neurol Neurosurg Psychiatry, 2015, 86(9): 973-985., articleTitle=null, refAbstract=null), Reference(id=1329529158184579504, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=Oaklander AL, Lunn MP, Hughes RA, et al. Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews[J]. Cochrane Database Syst Rev, 2017, 1(1): CD010369., articleTitle=null, refAbstract=null), Reference(id=1329529158306214321, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Van den Bergh PYK, van Doorn PA, Hadden RDM, et al. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force-second revision[J]. J Peripher Nerv Syst, 2021, 26(3): 242-268., articleTitle=null, refAbstract=null), Reference(id=1329529158432043442, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=Cintas P, Bouhour F, Cauquil C, et al. Current clinical management of CIDP with immunoglobulins in France: an expert opinion[J]. Rev Neurol (Paris), 2023, 179(8): 914-922., articleTitle=null, refAbstract=null), Reference(id=1329529158566261171, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=Van Schaik IN, Bril V, van Geloven N, et al. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial[J]. Lancet Neurol, 2018, 7(1): 35-46., articleTitle=null, refAbstract=null), Reference(id=1329529158771782068, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=Menon D, Barnett C, Bril V. Novel treatments in myasthenia gravis[J]. Front Neurol, 2020, 11: 538., articleTitle=null, refAbstract=null), Reference(id=1329529159023440309, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=Berger M. Subcutaneous IgG in neurologic diseases[J]. Immunotherapy, 2014, 6(1): 71-83., articleTitle=null, refAbstract=null), Reference(id=1329529159249932726, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=Bourque PR, Pringle CE, Cameron W, et al. Subcutaneous immunoglobulin therapy in the chronic management of myasthenia gravis: a retrospective cohort study[J]. PLoS One, 2016, 11(8): 159993., articleTitle=null, refAbstract=null), Reference(id=1329529159400927671, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=Pasnoor M, Bril V, Levine T, et al. Subcutaneous immunoglobulin in myasthenia gravis: results of a north american open label study[J]. Neuromus Disord, 2019, 29(Suppl 1): S125., articleTitle=null, refAbstract=null), Reference(id=1329529159564505528, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=Hameed S, Cascella M. Multifocal motor neuropathy[M]. Florida: StatPearls Publishing, 2024., articleTitle=null, refAbstract=null), Reference(id=1329529159732277689, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=Keddie S, Eftimov F, van den Berg LH, et al. Immunoglobulin for multifocal motor neuropathy[J]. Cochrane Database Syst Rev, 2022, 1(1): CD004429., articleTitle=null, refAbstract=null), Reference(id=1329529159962964410, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=Harbo T, Andersen H, Jakobsen J. Long-term therapy with high doses of subcutaneous immunoglobulin in multifocal motor neuropathy[J]. Neurology, 2010, 75(15): 1377-1380., articleTitle=null, refAbstract=null), Reference(id=1329529160181068220, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=Misbah SA, Baumann A, Fazio R, et al. A smooth transition protocol for patients with multifocal motor neuropathy going from intravenous to subcutaneous immunoglobulin therapy: an open-label proof-of-concept study[J]. J Peripher Nerv Sys, 2011, 16(2): 92-97., articleTitle=null, refAbstract=null), Reference(id=1329529161888149951, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=Jovanovich E, Karam C. Human immune globulin infusion in the management of multifocal motor neuropathy[J]. Degener Neurol Neuromuscul Dis, 2015, 6: 1-12., articleTitle=null, refAbstract=null), Reference(id=1329529162076893632, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=Danieli MG, Verga JU, Mezzanotte C, et al. Replacement and immunomodulatory activities of 20% Subcutaneous immunoglobulin treatment: a single-center retrospective study in autoimmune myositis and CVID patients[J]. Front Immunol, 2022, 12: 805705., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1329529145769439592, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, xref=1., ext=[AuthorCompanyExt(id=1329529145777828201, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, companyId=1329529145769439592, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1329529145786216810, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, companyId=1329529145769439592, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院药物临床研究中心,上海 200437)]), AuthorCompany(id=1329529146016903531, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, xref=2., ext=[AuthorCompanyExt(id=1329529146033680748, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, companyId=1329529146016903531, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai InnoClinic Pharmaceutical Development Co, Ltd., Shanghai 200437, China), AuthorCompanyExt(id=1329529146071429485, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, companyId=1329529146016903531, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海益临思医药开发有限公司,上海 200437)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2024.07.016, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2024.07.016, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2024.07.016, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2024.07.016, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1720540800000, fullTextJson=null, articleText=null, reference=null)
收藏切换
皮下注射人免疫球蛋白药物的临床研究进展
兰志龙 1 , 王磊 2 , 张松 2 , 李智慧 2 , 王俊龙 1, * , 倪娜 1, *
世界临床药物 | 综述评论 2024,45(7): 794-798
收起
收藏切换
世界临床药物 |综述评论 2024 , 45 (7) : 794 -798
皮下注射人免疫球蛋白药物的临床研究进展
全屏
[Author(id=1329529146180481391, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329529146390196593, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, authorId=1329529146180481391, language=EN, stringName=Zhilong LAN, firstName=Zhilong, middleName=null, lastName=LAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329529146620883314, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, authorId=1329529146180481391, language=CN, stringName=兰志龙, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国医药工业研究总院药物临床研究中心,上海 200437, bio={"content":"

兰志龙,硕士研究生,研究方向:临床药学及临床研究。

"}, bioImg=null, bioContent=

兰志龙,硕士研究生,研究方向:临床药学及临床研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329529145769439592, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, xref=1., ext=[AuthorCompanyExt(id=1329529145777828201, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, companyId=1329529145769439592, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1329529145786216810, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, companyId=1329529145769439592, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院药物临床研究中心,上海 200437)])]), Author(id=1329529146801238388, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329529148407656823, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, authorId=1329529146801238388, language=EN, stringName=Lei WANG, firstName=Lei, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Shanghai InnoClinic Pharmaceutical Development Co, Ltd., Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329529148562846072, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, authorId=1329529146801238388, language=CN, stringName=王磊, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.上海益临思医药开发有限公司,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329529146016903531, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, xref=2., ext=[AuthorCompanyExt(id=1329529146033680748, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, companyId=1329529146016903531, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai InnoClinic Pharmaceutical Development Co, Ltd., Shanghai 200437, China), AuthorCompanyExt(id=1329529146071429485, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, companyId=1329529146016903531, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海益临思医药开发有限公司,上海 200437)])]), Author(id=1329529148869030266, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329529148986470780, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, authorId=1329529148869030266, language=EN, stringName=Song ZHANG, firstName=Song, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Shanghai InnoClinic Pharmaceutical Development Co, Ltd., Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329529149233934717, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, authorId=1329529148869030266, language=CN, stringName=张松, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.上海益临思医药开发有限公司,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329529146016903531, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, xref=2., ext=[AuthorCompanyExt(id=1329529146033680748, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, companyId=1329529146016903531, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai InnoClinic Pharmaceutical Development Co, Ltd., Shanghai 200437, China), AuthorCompanyExt(id=1329529146071429485, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, companyId=1329529146016903531, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海益临思医药开发有限公司,上海 200437)])]), Author(id=1329529149351375231, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329529149426872705, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, authorId=1329529149351375231, language=EN, stringName=Zhihui LI, firstName=Zhihui, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Shanghai InnoClinic Pharmaceutical Development Co, Ltd., Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329529149552701826, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, authorId=1329529149351375231, language=CN, stringName=李智慧, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.上海益临思医药开发有限公司,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329529146016903531, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, xref=2., ext=[AuthorCompanyExt(id=1329529146033680748, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, companyId=1329529146016903531, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai InnoClinic Pharmaceutical Development Co, Ltd., Shanghai 200437, China), AuthorCompanyExt(id=1329529146071429485, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, companyId=1329529146016903531, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海益临思医药开发有限公司,上海 200437)])]), Author(id=1329529149649170820, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329529149728862598, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, authorId=1329529149649170820, language=EN, stringName=Junlong WANG, firstName=Junlong, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329529149812748679, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, authorId=1329529149649170820, language=CN, stringName=王俊龙, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.中国医药工业研究总院药物临床研究中心,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329529145769439592, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, xref=1., ext=[AuthorCompanyExt(id=1329529145777828201, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, companyId=1329529145769439592, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1329529145786216810, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, companyId=1329529145769439592, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院药物临床研究中心,上海 200437)])]), Author(id=1329529149955355017, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, orderNo=5, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329529150110544267, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, authorId=1329529149955355017, language=EN, stringName=Na NI, firstName=Na, middleName=null, lastName=NI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329529150269927820, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, authorId=1329529149955355017, language=CN, stringName=倪娜, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.中国医药工业研究总院药物临床研究中心,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329529145769439592, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, xref=1., ext=[AuthorCompanyExt(id=1329529145777828201, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, companyId=1329529145769439592, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1329529145786216810, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529142061674853, companyId=1329529145769439592, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院药物临床研究中心,上海 200437)])])]
兰志龙1, 王磊2, 张松2, 李智慧2, 王俊龙1, *, 倪娜1, *
作者信息
  • 1.中国医药工业研究总院药物临床研究中心,上海 200437
  • 2.上海益临思医药开发有限公司,上海 200437
通讯作者:
倪娜,副研究员,研究方向:创新药物的临床研究。
王俊龙,副研究员,研究方向:创新药物的临床研究。
作者简介:

兰志龙,硕士研究生,研究方向:临床药学及临床研究。

Progress in clinical research of subcutaneous immunoglobulin
Zhilong LAN1, Lei WANG2, Song ZHANG2, Zhihui LI2, Junlong WANG1, *, Na NI1, *
Affiliations
  • 1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
  • 2.Shanghai InnoClinic Pharmaceutical Development Co, Ltd., Shanghai 200437, China
出版时间: 2024-07-10 doi: 10.13683/j.wph.2024.07.016
文章导航
收藏切换

免疫球蛋白被认为可用于治疗多种疾病,不仅因其能够作为替代疗法对抗感染,而且还具有免疫调节作用。适当使用免疫球蛋白能挽救生命。然而,其给药途径可能会导致许多不良反应和潜在的其他不良后果,目前国内临床上使用的以静脉注射免疫球蛋白为主,但在临床使用过程中不良反应偏多,患者依从性也不高。迫于这种未被满足的临床需求,在国外研制出皮下注射人免疫球蛋白(subcutaneous immunoglobulin,SCIg),目前已在多个临床适应证领域被应用,但国内SCIg尚处于前期探索和研发阶段,面对国内巨大的临床需求,促使国内血液制品研发企业加快研发不同规格及针对不同适应证的SCIg药物。该文主要就SCIg在治疗原发性免疫缺陷病、自身免疫性神经肌肉疾病及其他罕见病领域最新临床研究进展作综述,以期为我国血液制品研发企业提供新的研发思路及建议。

皮下注射人免疫球蛋白  /  原发性免疫缺陷病  /  自身免疫性神经肌肉疾病  /  罕见病

Immunoglobulin is recognized to be used for the treatment of various diseases, not only because it can serve as an alternative therapy against infections, but also because of its immunomodulatory effects. Appropriate use of immunoglobulins can save lives. However, its route of administration may lead to many adverse events and potential other adverse consequences. At present, intravenous immunoglobulin is the main clinical use in China, but there are more adverse events in the process of clinical use, and the patient compliance is not high. Due to this unmet clinical need, subcutaneous immunoglobulin (SCIg) has been developed abroad, which has been used in multiple clinical indications. However, SCIg in China is still in the early stage of exploration and research and development. Faced with the huge clinical needs in China, domestic blood product research and development companies have been encouraged to accelerate the research and development of SCIg drugs of different specifications and different indications to meet the treatment needs of domestic patients. This article reviewed the latest clinical research progress of SCIg in the treatment of primary immunodeficiency diseases, autoimmune neuromuscular diseases and other rare diseases, in order to provide new research and development ideas and suggestions for blood product research and development enterprises in China.

subcutaneous immunoglobulin  /  primary immunodeficiency diseases  /  autoimmune neuromuscular diseases  /  rare diseases
兰志龙, 王磊, 张松, 李智慧, 王俊龙, 倪娜. 皮下注射人免疫球蛋白药物的临床研究进展. 世界临床药物, 2024 , 45 (7) : 794 -798 . DOI: 10.13683/j.wph.2024.07.016
Zhilong LAN, Lei WANG, Song ZHANG, Zhihui LI, Junlong WANG, Na NI. Progress in clinical research of subcutaneous immunoglobulin[J]. World Clinical Drug, 2024 , 45 (7) : 794 -798 . DOI: 10.13683/j.wph.2024.07.016

参考文献 引证文献
排序方式:
[1]
Mahlaoui N, Fouyssac F, Mazingue F, et al. Real-world experience with CLAIRYG® 50 mg/ml (intravenous immunoglobulin) in children under 12 years with primary immunodeficiency or immmune thrombocytopenia: a post-approval safety study[J]. Front Pediatr, 2023, 11: 1260296.
[2]
Marie I, Chérin P, Michallet M, et al. Management of adverse effects related to human immunoglobulin therapy: recommendations for clinical practice[J]. Rev Med Interne, 2017, 38(5): 312-319.
[3]
张巍, 徐继轩, 叶生亮, 等. 皮下注射免疫球蛋白的发展及临床应用[J]. 中国药房, 2020, 31(3): 378-384.
[4]
Späth PJ, Schneider C, von Gunten S. Clinical use and therapeutic potential of IVIg/SCIg, plasma-derived IgA or IgM, and other alternative immunoglobulin preparations[J]. Arch Immunol Ther Exp (Warsz), 2017, 65(3): 215-231.
[5]
Menon D, Sarpong E, Bril V. Practical aspects of transitioning from intravenous to subcutaneous immunoglobulin therapy in neuromuscular disorders[J]. Can J Neurol Sci, 2022, 49(2): 161-167.
[6]
Guo Y, Tian X, Wang X, et al. Adverse effects of immunoglobulin therapy[J]. Front Immunol, 2018, 9: 1299.
[7]
Pecoraro A, Crescenzi L, Granata F, et al. Immunoglobulin replacement therapy in primary and secondary antibody deficiency: the correct clinical approach[J]. Int Immunopharmacol, 2017, 52: 136-142.
[8]
Beecher G, Anderson D, Siddiqi ZA. Subcutaneous immunoglobulin in myasthenia gravis exacerbation: a prospective, open-label trial[J]. Neurology, 2017, 89(11): 1135-1141.
[9]
Anderson-Smits C, Park M, Bell J, et al. Subcutaneous immunoglobulin use in immunoglobulin-naive patients with primary immunodeficiency: a systematic review[J]. Immunotherapy, 2022, 14(5): 373-387.
[10]
Tangye SG, Al-Herz W, Bousfiha A, et al. Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee[J]. J Clin Immunol, 2020, 40(1): 24-64.
[11]
Farmer JR, Foldvari Z, Ujhazi B, et al. Outcomes and treatment strategies for autoimmunity and hyperinflammation in patients with RAG deficiency[J]. J Allergy Clin Immunol Pract, 2019, 7(6): 1970-1985.
[12]
Thalappil S, Khalil S, Hassini S, et al. Subcutaneous immunoglobulin therapy for adult patients with primary immunodeficiency disease: qatar experience[J]. Qatar Med J, 2023, (2): 3.
[13]
Milota T, Bloomfield M, Kralickova P, et al. Czech hizentra noninterventional study with rapid push: efficacy, safety, tolerability, and convenience of therapy with 20% subcutaneous immunoglobulin[J]. Clin Ther, 2019, 41(11): 2231-2238.
[14]
Bonilla FA. Intravenous and subcutaneous immunoglobulin G replacement therapy[J]. Allergy Asthma Proc, 2016, 37(6): 426-431.
[15]
Bonilla FA, Khan DA, Ballas ZK, et al. Practice parameter for the diagnosis and management of primary immunodeficiency[J]. J Allergy Clin. Immunol, 2015, 136(5): 1186-1205.
[16]
Krivan G, Jolles S, Granados EL, et al. New insights in the use of immunoglobulins for the management of immune deficiency (PID) patients[J]. Am J Clin Exp Immunol, 2017, 6(5): 76-83.
[17]
Jolles S, Stein MR, Longhurst HJ, et al. New frontiers in subcutaneous immunoglobulin treatment[J]. Biol Ther, 2011, 1(1): 3.
[18]
Hagan JB, Fasano MB, Spector S, et al. Efficacy and safety of a new 20% immunoglobulin preparation for subcutaneous administration, IgPro20, in patients with primary immunodeficiency[J]. J Clin Immunol, 2010, 30(5): 734-745.
[19]
Tortorici MA, Lawo JP, Weide R, et al. Privigen® has similar pharmacokinetic properties in primary and secondary immune deficiency[J]. Int Immunopharmacol, 2019, 66: 119-126.
[20]
Sanders DB. Advancing research in autoimmune neuromuscular disorders[J]. Lancet Neurol, 2022, 21(2): 108-110.
[21]
Farrugia ME, Vincent A. Autoimmune mediated neuromuscular junction defects[J]. Curr Opin Neurol, 2010, 23(5): 489-495.
[22]
Vallat JM, Sommer C, Magy L. Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition[J]. Lancet Neurol, 2010, 9(4): 402-412.
[23]
Mathey EK, Park SB, Hughes RAC, et al. Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype[J]. J Neurol Neurosurg Psychiatry, 2015, 86(9): 973-985.
[24]
Oaklander AL, Lunn MP, Hughes RA, et al. Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews[J]. Cochrane Database Syst Rev, 2017, 1(1): CD010369.
[25]
Van den Bergh PYK, van Doorn PA, Hadden RDM, et al. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force-second revision[J]. J Peripher Nerv Syst, 2021, 26(3): 242-268.
[26]
Cintas P, Bouhour F, Cauquil C, et al. Current clinical management of CIDP with immunoglobulins in France: an expert opinion[J]. Rev Neurol (Paris), 2023, 179(8): 914-922.
[27]
Van Schaik IN, Bril V, van Geloven N, et al. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial[J]. Lancet Neurol, 2018, 7(1): 35-46.
[28]
Menon D, Barnett C, Bril V. Novel treatments in myasthenia gravis[J]. Front Neurol, 2020, 11: 538.
[29]
Berger M. Subcutaneous IgG in neurologic diseases[J]. Immunotherapy, 2014, 6(1): 71-83.
[30]
Bourque PR, Pringle CE, Cameron W, et al. Subcutaneous immunoglobulin therapy in the chronic management of myasthenia gravis: a retrospective cohort study[J]. PLoS One, 2016, 11(8): 159993.
[31]
Pasnoor M, Bril V, Levine T, et al. Subcutaneous immunoglobulin in myasthenia gravis: results of a north american open label study[J]. Neuromus Disord, 2019, 29(Suppl 1): S125.
[32]
Hameed S, Cascella M. Multifocal motor neuropathy[M]. Florida: StatPearls Publishing, 2024.
[33]
Keddie S, Eftimov F, van den Berg LH, et al. Immunoglobulin for multifocal motor neuropathy[J]. Cochrane Database Syst Rev, 2022, 1(1): CD004429.
[34]
Harbo T, Andersen H, Jakobsen J. Long-term therapy with high doses of subcutaneous immunoglobulin in multifocal motor neuropathy[J]. Neurology, 2010, 75(15): 1377-1380.
[35]
Misbah SA, Baumann A, Fazio R, et al. A smooth transition protocol for patients with multifocal motor neuropathy going from intravenous to subcutaneous immunoglobulin therapy: an open-label proof-of-concept study[J]. J Peripher Nerv Sys, 2011, 16(2): 92-97.
[36]
Jovanovich E, Karam C. Human immune globulin infusion in the management of multifocal motor neuropathy[J]. Degener Neurol Neuromuscul Dis, 2015, 6: 1-12.
[37]
Danieli MG, Verga JU, Mezzanotte C, et al. Replacement and immunomodulatory activities of 20% Subcutaneous immunoglobulin treatment: a single-center retrospective study in autoimmune myositis and CVID patients[J]. Front Immunol, 2022, 12: 805705.
2024年第45卷第7期
12
1
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2024.07.016
  • 接收时间:2024-01-12
  • 首发时间:2026-11-17
  • 出版时间:2024-07-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2024-01-12
基金
作者信息
    1.中国医药工业研究总院药物临床研究中心,上海 200437
    2.上海益临思医药开发有限公司,上海 200437

通讯作者:

倪娜,副研究员,研究方向:创新药物的临床研究。
王俊龙,副研究员,研究方向:创新药物的临床研究。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2024.07.016
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏